Uruguayan laboratory dedicated to the production of high-quality cannabis extracts and oils. Full traceability, formulation under international standards.
Every product is manufactured under Good Manufacturing Practices from full-spectrum extract free of fats and waxes. Chromatographic analysis per batch and purity certificates included with every shipment.
Full-spectrum distillate of Cannabis sativa, free of fats, waxes and chlorophyll. API base for drops, suppositories, sprays, creams and ointments.
Pharmaceutical-grade full-spectrum oral solution. Available in 10 ml and 30 ml. Produced under GMP with guaranteed batch-to-batch dosing.
High concentration for treatments requiring higher daily doses. Same pharmaceutical quality as pk5, with a controlled cannabinoid profile.
We combine analytical chemistry, process engineering and IRCCA-approved raw material to produce derivatives with pharmaceutical consistency. Every batch is traceable from origin to final packaging.
Ethanolic extraction system at −20 °C that preserves the full cannabinoid and terpene profile without degrading heat-sensitive molecules.
High-resolution liquid chromatography on 100 % of batches. Certificate of analysis attached to every shipment with complete cannabinoid and terpene profile.
Internal traceability system integrated with the IRCCA registry. Every gram is linked to its raw-material batch, extraction date and responsible operator.
Team dedicated to the development of new products.
From raw material to final packaging, every step is sampled, analyzed and documented under good practices.
High-quality plant material supplied by authorized producers, with full traceability and documentary record.
Ethanolic process at low temperature. Preserves the full cannabinoid spectrum.
Filtration, winterization and decarboxylation under strict thermodynamic control.
Chromatographic, microbiological and contaminant analysis per batch. Certificate attached to every shipment.
Formulations suited to each use, employing pharmaceutical excipients.
We operate under IRCCA license, MGAP authorization and ANVISA Brazil registration under RDC 660. Authorization from the Ministry of Public Health and GMP certification are in progress.
IRCCAInstitute for the Regulation and Control of Cannabis · Uruguay
MGAPMinistry of Livestock, Agriculture and Fisheries · Uruguay
MSPMinistry of Public Health · Uruguay
GMPGood Manufacturing Practice · International
ANVISANational Health Surveillance Agency · Brazil
IRCCAInstitute for the Regulation and Control of Cannabis · Uruguay
MGAPMinistry of Livestock, Agriculture and Fisheries · Uruguay
MSPMinistry of Public Health · Uruguay
GMPGood Manufacturing Practice · International
ANVISANational Health Surveillance Agency · Brazil
Book a 30-minute call to review your volume, markets and formulation needs. We respond within 48 business hours.